Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| C02CA04 | UNIPROST | G | Doxazosin - 4mg | 4mg | Tablet | 452874.9225 |
| C02AC05 | CYNT | B | Moxonidine - 0.2mg | 0.2mg | Tablet, film coated | 937444.398891 |
| C02AC05 | CYNT | B | Moxonidine - 0.3mg | 0.3mg | Tablet, film coated | 1266372.258151 |
| C02AC05 | CYNT | B | Moxonidine - 0.4mg | 0.4mg | Tablet, film coated | 1266372.258151 |
| C02AB02 | ALDOMET | B | Methyldopa - 250mg | 250mg | Tablet, coated | 644399.578823 |
| C02AB02 | ALDOMET | B | Methyldopa - 500mg | 500mg | Tablet, coated | 856707.560709 |
| C01EX | CARDIOVITEX | G | Coenzyme Q10 - 300mg, Magnesium oxide - 100mg | Tablet | 2822069.25 | |
| C01EB18 | RANEXA | B | Ranolazine - 375mg | 375mg | Tablet, prolonged release | 3985836.855 |
| C01EB18 | RANEXA | B | Ranolazine - 500mg | 500mg | Tablet, prolonged release | 3985836.855 |
| C01EB18 | RANEXA | B | Ranolazine - 750mg | 750mg | Tablet, prolonged release | 3985836.855 |
| C01EB17 | PROCORALAN | B | Ivabradin (HCl) - 5mg | 5mg | Tablet, film coated | 1890786.3975 |
| C01EB17 | BRADIREM | G | Ivabradine (HCl) - 5mg | 5mg | Tablet, film coated | 1134203.07 |
| C01EB17 | BRAVIGO | G | Ivabradine (HCl) - 5mg | 5mg | Tablet, film coated | 1237678.9425 |
| C01EB17 | IVABRADINE ARROW | G | Ivabradine (HCl) - 5mg | 5mg | Tablet, film coated, scored | 1323684.8625 |
| C01EB17 | PROCORALAN | B | Ivabradin (HCl) - 7.5mg | 7.5mg | Tablet, film coated | 1890786.3975 |
| C01EB17 | BRADIREM | G | Ivabradine (HCl) - 7.5mg | 7.5mg | Tablet, film coated | 1134203.07 |